Dr. David M. Poppers is Assistant Professor of Medicine at the NYU School of Medicine and an attending gastroenterologist at the Columbus Medical practice of NYU Langone Medical Center and at Bellevue Hospital Center.
Board certified in both Internal Medicine and Gastroenterology, Dr. Poppers specializes in colon cancer screening, gastrointestinal bleeding, general gastroenterology, and the diagnosis and treatment of inflammatory bowel disease (such as Crohn's disease and ulcerative colitis) and conditions of the small intestine. Dr. Poppers is trained and experienced in performing colonoscopy and upper endoscopy, as well as advanced endoscopic procedures such as capsule endoscopy, endoscopic retrograde cholangiopancreatography (ERCP), and balloon-assisted enteroscopy, including single- and double-balloon enteroscopy procedures.
Dr. Poppers' prior research interests involve the study of serologic markers and treatments in inflammatory bowel disease and the use of capsule endoscopy and deep enteroscopy in the detection and treatment of polyps, ulcers, malignancies, and inflammatory conditions of the small intestine. Dr. Poppers has contributed numerous articles and abstracts, as well as a book chapter, to the scientific literature. He is a member of the American Gastroenterological Association and American Society for Gastrointestinal Endoscopy.
Dr. Poppers received his master of science (MSc) degree and PhD from the NYU School of Medicine, where he also went on to receive his medical degree. He underwent his internship and residency in Internal Medicine at Massachusetts General Hospital and completed his clinical fellowship at Harvard Medical School and his Gastroenterology fellowship at NewYork-Presbyterian/Weill Cornell Medical Center. He completed an additional fellowship in Interventional Endoscopy at Lenox Hill Hospital in New York City.
Insurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.
All data from NYU Health Sciences Library Faculty Bibliography — -
Double balloon discovers double capsules
McCabe, Evin J; Haber, Gregory B; Poppers, David M; Rosen, Eric S; O'Connor, Ryan M
2008 Aug;68(2):377-8; discussion 378, Gastrointestinal endoscopy
— id: 86618, year: 2008, vol: 68, page: 377, stat: Journal Article,
Seizures in an Alzheimer's disease patient as a complication of colonoscopy premedication with meperidine
Nagler, Jerry; Hammarth, Patricia M; Poppers, David M
2008 Jan;53(1):62-64, Digestive diseases & sciences
— id: 86621, year: 2008, vol: 53, page: 62, stat: Journal Article,
Endoscopic mucosal resection of colonic lesions: current applications and future prospects
Poppers, David M; Haber, Gregory B
2008 May;92(3):377-8; discussion 378, Medical clinics of North America
— id: 86619, year: 2008, vol: 92, page: 377, stat: Journal Article,
Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: toward a standard of care
Poppers, David M; Scherl, Ellen J
2008 Jan;14(1):106-113, Inflammatory bowel diseases
— id: 86620, year: 2008, vol: 14, page: 106, stat: Journal Article,
Severe hyponatremia and seizure following a polyethylene glycol-based bowel preparation for colonoscopy
Nagler, Jerry; Poppers, David; Turetz, Meredith
2006 Jul;40(6):558-559, Journal of clinical gastroenterology
— id: 86622, year: 2006, vol: 40, page: 558, stat: Journal Article,
Persistent tumor necrosis factor signaling in normal human fibroblasts prevents the complete resynthesis of ikappa B-alpha [In Process Citation]
Poppers DM; Schwenger P; Vilcek J
2000 Sep 22;275(38):29587-29593, Journal of biological chemistry
— id: 15528, year: 2000, vol: 275, page: 29587, stat: Journal Article,
Persistent TNF signaling in normal human fibroblasts prevents complete IkappaB resynthesis
Poppers, David M; Schwenger, Paul; Vilcek, Jan
1999 Sep 5-9;19(SUPPL. 1):S105-S105, Journal of interferon & cytokine research
— id: 15888, year: 1999, vol: 19, page: S105, stat: Journal Article,
TNF/IL-1-inducible protein TSG-6 potentiates plasmin inhibition by inter-alpha-inhibitor and exe